VRAX: Wutah pendapatan triwulanan Virax Biolabs Group

Simbol lan logo merek viraxbiolabs.com (VRAX)

Diversification into oncology diagnostics expands the market horizons of Virax Biolabs Group (VRAX). The quarterly revenue growth rate visualizes this potential, and its latest mark stands at 685.90. Stable cash flow is secured by long-term contracts for Inertia consumables, while the technological advantage of Robotization is based on the automation of PCR processes, which minimizes routine laboratory labor and increases research accuracy.

Virax Biolabs Corp (VRAX) - Wutah dodolan kuartal marang kuartal saka 28.04.2023 nganti 20.11.2026

Virax Biolabs - rincian analitis lan metrik utama (VRAX)

- kuotasi saiki lan rata-rata prakiraan nilai:
- data dhuwit lan arus kas:
Analisis fundamental perusahaan:VRAX - Virax Biolabs Group Limited
Produk sing diprodhuksi viraxbiolabs.com

Geopolitical fragmentation and barriers in the exchange of diagnostic tests directly impact the expansion of Virax Biolabs Group (VRAX), making the monitoring of sales dynamics critical. Analyzing the quarterly revenue growth rate allows for the measurement of percentage income increases relative to the previous period, identifying tail risks and the business model's resilience to macroeconomic cooling to ensure the timely optimization of the investment portfolio.

Pesaing utama

A - Wutah pendapatan kuartal marang kuartal|Tingkat wutah dodolan sajrone kuartal Quest Diagnostics Incorporated DGX|ILMN (illumina.com) - Wutah dodolan triwulanan|Wutah dodolan triwulanan Cologuard|RVTY (Revvity Corp) - Wutah pendapatan triwulanan|Wutah pendapatan triwulanan Bio-Rad Laboratories Inc|Wutah dodolan triwulanan NNNN (Anbio Biotechnology)|SHC (Sotera Health Company) - Tambahing pendapatan triwulanan|Wutah pendapatan kuartal marang kuartal QuidelOrtho Inc. QDEL|Wutah pendapatan triwulanan OPKO Health Inc OPK|CareDx Inc - Wutah pendapatan triwulanan|Tambahing pendapatan triwulanan MRVI (Maravai)|FLGT: Wutah pendapatan triwulanan|LAB (Standard BioTools Inc.) - Wutah pendapatan kuartal marang kuartal|Wutah pendapatan kuartal marang kuartal Cytek Biosciences Inc|Tingkat wutah pendapatan sajrone kuartal OraSure OSUR|Wutah dodolan triwulanan XGN (Exagen Diagnostics)|Tingkat wutah dodolan sajrone kuartal MDxHealth Inc.|Wutah pendapatan kuartal marang kuartal Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Tingkat wutah pendapatan sajrone kuartal|Insight Molecular Diagnostics Inc - Wutah pendapatan triwulanan|Tingkat wutah pendapatan sajrone kuartal trinitybiotech.com|PRPH (ProPhase) - Wutah dodolan triwulanan|Wutah dodolan kuartal marang kuartal AIMD|Wutah dodolan triwulanan CODX|Tingkat wutah pendapatan sajrone kuartal heartsciences.com HSCS|Wutah pendapatan kuartal marang kuartal Biomerica Inc. (BMRA)|Tingkat wutah dodolan sajrone kuartal Cardio Diagnostics Holdings|Wutah pendapatan triwulanan ONCO (Onconetix Corporation)|Tingkat wutah dodolan sajrone kuartal Bluejay (BJDX)|AWH: Wutah dodolan triwulanan|Tingkat wutah dodolan sajrone kuartal Accelerate Diagnostics, Inc. AXDX|Centogene (CNTG) - Wutah pendapatan kuartal marang kuartal|Dinamika pendapatan kuartal marang kuartal ENZ (Enzo)|Wutah dodolan kuartal marang kuartal Fresh2 (FRES)|Genetic Technologies (GENE) - Tingkat wutah dodolan sajrone kuartal|Wutah pendapatan triwulanan ME|Wutah pendapatan kuartal marang kuartal PMD (Psychemedics Corporation)